Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3541
    PDF: 2404
    HTML: 1459
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2184
    PDF: 1481
    HTML: 264
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    1921
    PDF: 503
    HTML: 536
  • LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

    Andrea Riccardo Filippi
    e2016041
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.041
    3692
    PDF: 1087
    HTML: 2291
    Figure 1: 211
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2448
    PDF: 783
    HTML: 1735
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5522
    PDF: 2314
    HTML: 1325
  • An unusual cause of anemia and encephalopathy

    Sanjeev Kumar Sharma, Dharma Choudhary, Anil Handoo, Gaurav Dhamija, Gaurav Kharya, Vipin Khandelwal, Mayank Dhamija, Sweta Kothari
    e2015036
    2015-04-24
    https://doi.org/10.4084/mjhid.2015.036
    3886
    PDF: 856
    HTML: 1509
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    1983
    PDF: 1123
    HTML: 620
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2062
    PDF: 837
    HTML: 163
  • INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

    Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley
    e2013023
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.023
    1954
    PDF: 711
    HTML: 681
    Table1: patient's characteristics: 155
    Table 2: profile of each patient: 178
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1163
    PDF: 602
    HTML: 6797
  • DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE

    avinash kumar singh, tulika seth, nita radhakrishnan, pravas mishra, manoranjan mahapatra, haraprasad pati
    e2013039
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.039
    1802
    PDF: 852
    HTML: 3594
    Diamond Blackfan Anemia: A Tertiary care centre experience: 255
  • Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

    Claudio Fozza
    e2024011
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.011
    1613
    PDF: 1337
    HTML: 179
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1165
    PDF: 740
    HTML: 582
  • THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

    Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt
    e2017019
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.019
    4101
    PDF: 1935
    HTML: 1763
  • CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN

    Naouel GUIRAT, Monia Ben Khaled, Monia Ouederni, Imen Ben-Mustapha, Ridha Kouki, Habib Besbes, Mohamed Ridha Barbouche, Fethi Mellouli, mohamed bejaoui
    e2018065
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.065
    1830
    PDF: 1129
    HTML: 352
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1624
    PDF: 647
    HTML: 43905
  • HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando
    e2021011
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.011
    1594
    PDF: 578
    HTML: 224
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    1715
    PDF: 1161
    HTML: 245
  • IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

    Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay
    e2022053
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.053
    999
    PDF: 692
    HTML: 221
  • MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

    Maria Ilaria Del Principe
    e2016052
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.052
    4653
    PDF: 1311
    HTML: 1911
    Untitled: 180
    Untitled: 175
  • How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

    Marco Sanna, Giovanni Caocci, Giorgio La Nasa
    e2017047
    2017-08-14
    https://doi.org/10.4084/mjhid.2017.047
    1826
    PDF: 905
    HTML: 953
    Referring article: 748
  • Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma

    Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser
    e2012063
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.063
    1410
    PDF: 724
    HTML: 4550
    Figure 1: Chest radiograph: 211
    Figure 2: Flow cytometer analysis of pleural fluid: 183
  • INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

    Giuseppe La Torre
    e2016044
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.044
    4678
    PDF: 1475
    HTML: 3140
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9042
    PDF: 6052
    HTML: 87949
    Fig.1b: 183
    Fig.1c: 188
    Fig.2a: 176
    Fig.2b: 175
    Fig.4: 188
    Fig.2c: 183
    Fig.3: 181
    Tab.1: 225
    Tab.2: 206
    Tab.3: 188
    Tab.4: 220
    Fig1a: 181
  • PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

    Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag
    e2011055
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.055
    1865
    PDF: 754
    HTML: 1514
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1010
    PDF: 979
    HTML: 153
  • Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

    Maria Cristina Rapanotti
    e2018059
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.059
    1316
    PDF: 761
    HTML: 150
  • Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

    Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci
    e2012035
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.035
    1529
    PDF: 742
    HTML: 644
  • CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Daichi Inoue, Hayato Maruoka, Takayuki Takahashi
    e2010020
    2010-08-05
    https://doi.org/10.4084/mjhid.2010.020
    1259
    PDF: 753
    HTML: 1164
  • Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

    Serdar Sivgin
    e2013006
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.006
    1138
    PDF: 630
    HTML: 3245
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1420
    PDF: 1386
    HTML: 187
  • MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

    Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar
    e2018002
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.002
    3612
    PDF: 1193
    HTML: 1083
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    3670
    PDF: 1281
    HTML: 727
    Figure 2: 452
    Figure 1: 3116
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    835
    PDF: 486
    HTML: 1302
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    11053
    PDF: 4322
    HTML: 4344
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    1895
    PDF: 1630
    HTML: 122
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1886
    PDF: 1009
    HTML: 1336
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1514
    PDF: 799
    HTML: 153
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    946
    PDF: 1204
    HTML: 108
  • MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

    Davide Matino, Paul Tieu, Dr., Antony Chan
    e2020001
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.001
    3233
    PDF: 1610
    HTML: 424
  • A PROSPECTIVE STUDY OF BRUCELLOSIS IN CHILDREN: RELATIVE FREQUENCY OF PANCYTOPENIA

    Mohamed El Koumi, Mona Afify, Salha Al-Zahrani
    e2013011
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.011
    2183
    PDF: 833
    HTML: 4014
  • A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

    Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani
    e2012017
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.017
    1169
    PDF: 657
    HTML: 749
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    998
    PDF: 627
    HTML: 2212
  • HHVs AND LYMPHOPROLIFERATIVE DISORDERS

    C Quadrelli, P Barozzi, G Riva, Mario Luppi
    e2011043
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.043
    1381
    PDF: 816
    HTML: 3121
  • PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

    Anna Falanga, Laura Russo, Carmen J Tartari
    e2011068
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.068
    1803
    PDF: 806
    HTML: 10233
    Figures 1,2,3: 173
  • EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

    Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew
    e2013007
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.007
    1343
    PDF: 655
    HTML: 2498
    cover letter: 192
  • Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

    Lorenza Torti, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili
    e2012008
    2012-01-25
    https://doi.org/10.4084/mjhid.2012.008
    1835
    PDF: 832
    HTML: 1579
  • Respiratory function in pediatric African SCA patients underwent bone marrow transplantation

    Antonella Isgrò, Javid Gaziev, Marco Marziali, Katia Paciaroni, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Festus Olusola Olowoselu, Guido Lucarelli
    e2017030
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.030
    2116
    PDF: 757
    HTML: 1042
    Spirometry in SCA patients before transplant: 200
    Spirometry in SCA patients post transplant: 180
  • Rubella associated with hemophagocytic syndrome. First report in a male and review of the literature

    Makram Koubaa, Chakib Marrakchi, Imed Mâaloul, Saloua Makni, Lamia Beraajah, Moez Elloumi, Boussaima Hammami, Dorra Lahiani, Tahia Boudawara, Mounir Ben Jemâa
    e2012050
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.050
    1208
    PDF: 769
    HTML: 3738
151 - 200 of 459 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy